Online Inquiry
Your Information Is Secure. We Respect Your Privacy And Never Spam.
Alfa Cytology's cutting-edge services and expertise provide comprehensive preclinical solutions for lung cancer therapy development. Backed by state-of-the-art technologies, end-to-end project support, and tailored development strategies, Alfa Cytology ensures seamless progress from concept to clinical readiness, empowering innovation in lung cancer therapy.
Lung cancer is the third most common cancer in the United States, and the development of new therapies is urgent. Based on a dedicated team of experts and an advanced technology platform, Alfa Cytology provides one-stop solutions for preclinical therapy development for different types of lung cancer.
Non-small cell lung cancer (NSCLC)
Small cell lung cancer (SCLC)
Lung cancer therapies face challenges, such as resistance, toxicity, the metastatic nature of the disease, lack of early detection, and limited therapy options. From early-stage research to late-stage preclinical validation, Alfa Cytology’s solutions cater to emerging biotech startups and established pharmaceutical companies, supporting a wide range of therapeutic approaches, including small molecules, biologics, and personalized drugs.
Small Molecule Inhibitors
Targeted Therapy
Immunotherapy
Cell Therapy
Epigenetic Therapy
Gene Therapy
As a leading international preclinical service provider, Alfa Cytology’s specialized offerings include advanced disease modeling, high-throughput drug screening, biomarker discovery, and integrated pharmacokinetic and toxicological studies. Overall, we offer a one-stop solution from mechanistic studies to preclinical evaluation of therapies.
Learn MoreThe animal model of lung cancer is a key tool to study the pathogenesis, drug screening, and therapeutic effect evaluation of lung cancer. With deep experience in animal model development, Alfa Cytology is committed to providing customers with highly stable and accurately matched animal model solutions to facilitate breakthroughs and innovations in lung cancer research.
Chemical Induction Model
Chemical Induction Model
Genetically Engineered Mouse Model (GEMMs)
Genetically Engineered Mouse Model (GEMMs)
Xenograft Models
Xenograft Models
Orthotopic Models
Orthotopic Models
Transgenic Model
Transgenic Model
Virus Induction Model
Virus Induction Model
Spontaneous Model
Spontaneous Model
Immune Humanized Model
Immune Humanized Model
The Lung Cancer Bioinformatics Platform leverages the power of precisely collated lung cancer data, computational science, and bioinformatics to reveal lung cancer's pathogenesis and therapeutic targets. Advance your lung cancer pipeline with faster model selection, AI data analysis, and visualization.
Explore MoreAlfa Cytology’s Lung Cancer Animal Model Platform combines precision engineering, innovative genetic technologies, and extensive expertise to deliver highly reliable and customizable models for lung cancer research. From chemically induced to genetically engineered and patient-derived xenograft models, our platform accelerates your preclinical pipeline by enabling faster model selection, accurate disease replication, and actionable insights into tumor biology and therapeutic efficacy. Empower your lung cancer research with models that truly mimic human disease, driving breakthroughs in drug discovery and development.
Explore More
Project Consulting and Demand Analysis
Program Design and Protocol Formulation
Project Start-up and Resource Allocation
Experiment Execution and Data Collection
Data Analysis and Verification
Report Writing and Delivery
Project Summary and Follow-up Support
Quality Assurance and Compliance
Intellectual Property and Confidentiality
How to order specific services from Alfa Cytology?
At Alfa Cytology, we offer one-stop preclinical development solutions for lung cancer therapy, as well as customizable modular services tailored to your specific project needs. You can reach out to our team via email (), phone (), or our website’s contact form to discuss your project requirements and provide details about your research goals, such as the type of service needed (e.g., animal models, drug screening, biomarker discovery) and any specific timelines or deliverables.
Does Alfa Cytology provide service in the clinical stage of lung cancer therapy/pipeline?
Alfa Cytology currently focuses on providing preclinical services for therapy development and validation. While we are continuously optimizing and exploring opportunities to expand our offerings, we do not yet provide services for the clinical stage of lung cancer therapy. However, we are actively working on advancements in this area and will promptly announce any new developments or services for the clinical stage in the future. Thank you for your interest!
What is the clinical significance of new therapy development for lung cancer?
Lung cancer remains one of the most challenging cancers to treat due to its high heterogeneity, late-stage diagnosis, and resistance to conventional therapies. Developing new therapies is crucial to improving survival rates and quality of life for patients. Innovative treatments, such as targeted therapies and immunotherapies, offer hope by addressing specific genetic mutations and enhancing the immune system's ability to fight cancer. Alfa Cytology supports this critical mission by providing advanced preclinical services, including in vitro and in vivo models, to accelerate the development and validation of novel lung cancer therapies. Our expertise ensures that researchers can efficiently transition from discovery to clinical applications, ultimately contributing to better outcomes.
How long is the project cycle for Alfa Cytology?
Alfa Cytology will respond to emails within 24 hours of receipt. However, the specific project cycle depends on the details of the project. Our expert team will carefully plan the timeline and provide a prompt response regarding the estimated duration. Thank you for your understanding!
As a service provider for preclinical development of lung cancer therapies, Alfa Cytology has the technology, resources, experience and customer service to differentiate itself in a highly competitive market.
About Us
